India to Nigeria: Strip Export Trade Route

The India to Nigeria Strip corridor is one of India's established pharmaceutical export routes, with 136 shipments documented worth a combined $6.3M USD. The route is dominated by SVIZERA LABS PRIVATE LIMITED, which alone accounts for roughly 51% of all export value, reflecting the consolidated nature of India's strip manufacturing sector.

Across 17 active suppliers, the average shipment value stands at $46.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (67%) and air (16%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during January–March, with an average transit time of 32 days port-to-port. The route has recorded an annual growth rate of 15.2%, placing it at rank #18 among India's top strip export destinations globally.

On the import side, key buyers of Indian strip in Nigeria include National Tuberculosis and Leprosy , DR LABARAN SHEHU, NATIONAL TUBERCULOSIS AND LEPROSY and 21 others. National Tuberculosis and Leprosy is the single largest importer with 10 shipments valued at $2.1M USD.

India's strip exports to Nigeria are driven primarily by a handful of large-scale manufacturers. SVIZERA LABS PRIVATE LIMITED with 34 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 17 active exporters signals a competitive but concentrated market — buyers in Nigeria benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — SVIZERA LABS PRIVATE LIMITED, MANEESH PHARMACEUTICALS LIMITED , SUN PHARMACEUTICAL INDUSTRIES LIMITED — together account for 94% of total trade value on this route. The average shipment value of $46.2K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as 12 strips of 28 tablets each of rifampic and 12 strips of 28 tablets each of rifampicin 150 mg/ isoniazid 75 mg tablets(6431x12), suggesting that buyers in Nigeria tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, National Tuberculosis and Leprosy is the largest importer with 10 shipments worth $2.1M USD — representing 34% of all strip imports from India on this route. A total of 24 buyers are active on this corridor.